VIP and the skin
- 13 April 1991
- journal article
- editorial
- Published by Elsevier in The Lancet
- Vol. 337 (8746) , 886-888
- https://doi.org/10.1016/0140-6736(91)90209-8
Abstract
No abstract availableThis publication has 30 references indexed in Scilit:
- Substance P‐, VIP‐ and CGRP‐like immunoreactivities coexist in a population of cholinergic postganglionic sympathetic nerves innervating sweat glands in the catActa Physiologica Scandinavica, 1998
- Vasoactive intestinal peptide (VIP) and peptide histidine methionine (PHM) in human eccrine sweat glands: demonstration of innervation, specific binding sites and presence in secretionsBritish Journal of Dermatology, 1990
- Absence of Immunoreactive Vasoactive Intestinal Polypeptide in Tissue from the Lungs of Patients with AsthmaNew England Journal of Medicine, 1989
- Vasoactive Intestinal Peptide as a Regulator of Exocrine Function and as a Possible Factor in Cystic FibrosisAnnals of the New York Academy of Sciences, 1988
- Local effect of vasoactive intestinal polypeptide on human sweat-gland function.The Japanese Journal of Physiology, 1987
- Immunoreactivity to Material like Vasoactive Intestinal Polypeptide in Epidermal Cells of Lichen Sclerosis et AtrophicusThe American Journal of Dermatopathology, 1986
- Remission of symptoms during long term treatment of metastatic pancreatic endocrine tumours with long acting somatostatin analogue.BMJ, 1986
- VIP-immunoreactivity in the skin of various mammals: Immunohistochemical, radioimmunological and experimental evidence for a dual localization in cutaneous nerves and Merkel cellsPeptides, 1984
- Human preprovasoactive intestinal polypeptide contains a novel PHI-27-like peptide, PHM-27Nature, 1983
- Distribution of bombesin, somatostatin, substance-P and vasoactive intestinal polypeptide in feline and porcine skinLife Sciences, 1983